Pharmaceuticals

The Rising Prevalence Of Arthritis Is Fueling The Growth Due To Increasing Aging Populations And Musculoskeletal Conditions Is Contributing To Changes In The In-Vitro Lung Model Market

April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The In-Vitro Lung Model Market Compare Between 2026 And 2030?

The in-vitro lung model market has experienced significant expansion in recent years. This market is anticipated to grow from $0.54 billion in 2025 to $0.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.0%. The growth observed in the past can be ascribed to factors such as the limitations inherent in animal models for respiratory research, the consistent utilization of two-dimensional lung cell cultures, an increase in research activities related to respiratory diseases, the progression of academic lung biology research, and the early adoption of organoid-based research methodologies.

The in-vitro lung model market is poised for significant expansion in the coming years. Projections indicate it will reach $1.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.6%. This anticipated growth during the forecast period stems from several factors, including a surging need for predictive preclinical lung models, a heightened emphasis on minimizing animal testing, the broadening of respiratory drug development pipelines, increased capital expenditure in sophisticated in-vitro research instruments, and the requirement for more physiologically accurate lung disease models. Key trends anticipated during this period encompass the wider embrace of three-dimensional lung models in pharmaceutical research, the expanding application of lung-on-a-chip platforms for simulating diseases, a growing inclination towards human-relevant in-vitro lung assessment systems, the extended use of in-vitro lung models in toxicology and safety evaluations, and enhanced incorporation of these models into preclinical research workflows.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Leading Drivers Are Supporting The In-Vitro Lung Model Market Expansion?

The in vitro lung model market is expected to experience future growth, primarily driven by an increase in clinical studies. Clinical studies involve research investigations conducted to evaluate the safety, effectiveness, and outcomes of new medical treatments, drugs, or diagnostic tools in humans. The rising number of these studies is a result of growing healthcare needs, an increased demand for advanced medical treatments, and the ongoing pursuit of innovative solutions for complex health conditions. The in vitro lung model market provides essential support for clinical research by offering controlled systems that enable drug testing, toxicity evaluation, disease modeling, and the analysis of lung-specific biological responses. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,230 registered clinical trials globally by the end of 2023, representing an increase from the 437,508 trials recorded in 2022. Thus, the expansion of clinical studies is significantly propelling the in vitro lung model market.

What Segment Categories Shape The In-Vitro Lung Model Market Segment Landscape?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Trends Are Affecting The Direction Of The In-Vitro Lung Model Market?

Major companies operating in the in vitro lung model market are actively developing advanced 3D respiratory tissue models, aiming to enhance their physiological relevance, improve predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model refers to a three-dimensional structure grown in a laboratory, composed of primary or specialized respiratory cells cultured in conditions that enable them to mimic the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal. This 3D respiratory tissue model, created from primary human nasal epithelial cells, replicates functional features of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, thereby providing researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

Who Are The Companies Operating Across The In-Vitro Lung Model Market Value Chain?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Get The Full In-Vitro Lung Model Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Holds The Highest Market Share In The In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized In-Vitro Lung Model Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Lung Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Pulmonary Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795